Comment on

• Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.

  Schmutz M, Brugger F, Gentsch C, McLean MJ, Olpe HR. Schmutz M, et al. Epilepsia. 1994;35 Suppl 5:S47-50. doi: 10.1111/j.1528-1157.1994.tb05967.x. Epilepsia. 1994. PMID: 8039471
• Oxcarbazepine: clinical development program.

  Schwabe S. Schwabe S. Epilepsia. 1994;35 Suppl 5:S51-3. doi: 10.1111/j.1528-1157.1994.tb05968.x. Epilepsia. 1994. PMID: 8039472
• Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy.

  Aliberti V, Grünewald RA, Panayiotopoulos CP, Chroni E. Aliberti V, et al. Epilepsia. 1994 Mar-Apr;35(2):297-301. doi: 10.1111/j.1528-1157.1994.tb02433.x. Epilepsia. 1994. PMID: 8156947
• Clinical and EEG asymmetries in juvenile myoclonic epilepsy.

  Lancman ME, Asconapé JJ, Penry JK. Lancman ME, et al. Epilepsia. 1994 Mar-Apr;35(2):302-6. doi: 10.1111/j.1528-1157.1994.tb02434.x. Epilepsia. 1994. PMID: 8156948